BIOMAT Database Logo BIOMAT Database Logo

Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine. 1994

K M Lawrence, and C L Katona, and M T Abou-Saleh, and M M Robertson, and B L Nairac, and D R Edwards, and T Lock, and R A Burns, and D A Harrison, and R W Horton
Department of Pharmacology and Clinical Pharmacology, St. George's Hospital Medical School, London, UK.

Platelet [3H] paroxetine binding was measured in 73 depressed patients and in 64 healthy volunteers. No differences were found in Bmax or Kd either overall, or when the 61 depressed subjects who had never received psychotropic drugs were analysed separately. Within the depressed group, no differences in Bmax or Kd were found between subgroups divided on the basis of endogenicity, suicidal thoughts or severity of depression. None of the subgroups differed significantly from controls. Forty of the depressed subjects were retested after 6 weeks' treatment with fluoxetine (n = 22) or lofepramine (n = 18). Treatment was not associated with any change in Bmax but a similar and significant increase in Kd was noted following treatment with either antidepressant. Neither pre- nor post-treatment platelet binding parameters appeared to relate to clinical response to treatment.

UI MeSH Term Description Entries
D008127 Lofepramine A psychotropic IMIPRAMINE derivative that acts as a tricyclic antidepressant and possesses few anticholinergic properties. It is metabolized to DESIPRAMINE. Lopramine,Deftan,Feprapax,Gamanil,Gamonil,Leo 640,Lofepramine Hydrochloride,Lomont,Hydrochloride, Lofepramine
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005473 Fluoxetine The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Fluoxetin,Fluoxetine Hydrochloride,Lilly-110140,N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,Prozac,Sarafem,Lilly 110140,Lilly110140

Related Publications

K M Lawrence, and C L Katona, and M T Abou-Saleh, and M M Robertson, and B L Nairac, and D R Edwards, and T Lock, and R A Burns, and D A Harrison, and R W Horton
Platelet [3H]paroxetine binding to 5-HT uptake sites in Alzheimer's disease.
January 1991, Neurobiology of aging,
K M Lawrence, and C L Katona, and M T Abou-Saleh, and M M Robertson, and B L Nairac, and D R Edwards, and T Lock, and R A Burns, and D A Harrison, and R W Horton
Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine.
January 1993, Psychopharmacology,
K M Lawrence, and C L Katona, and M T Abou-Saleh, and M M Robertson, and B L Nairac, and D R Edwards, and T Lock, and R A Burns, and D A Harrison, and R W Horton
Dopamine uptake sites, labelled with [3H]GBR12935, in brain samples from depressed suicides and controls.
November 1997, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
K M Lawrence, and C L Katona, and M T Abou-Saleh, and M M Robertson, and B L Nairac, and D R Edwards, and T Lock, and R A Burns, and D A Harrison, and R W Horton
Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.
October 1990, Journal of affective disorders,
K M Lawrence, and C L Katona, and M T Abou-Saleh, and M M Robertson, and B L Nairac, and D R Edwards, and T Lock, and R A Burns, and D A Harrison, and R W Horton
Platelet 5-HT transport in depressed patients under double-blind treatment with paroxetine versus amitriptyline.
January 1989, Acta psychiatrica Scandinavica. Supplementum,
K M Lawrence, and C L Katona, and M T Abou-Saleh, and M M Robertson, and B L Nairac, and D R Edwards, and T Lock, and R A Burns, and D A Harrison, and R W Horton
Platelet 3H-paroxetine binding in depressed patients.
October 1988, Psychiatry research,
K M Lawrence, and C L Katona, and M T Abou-Saleh, and M M Robertson, and B L Nairac, and D R Edwards, and T Lock, and R A Burns, and D A Harrison, and R W Horton
Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.
June 1997, Journal of affective disorders,
K M Lawrence, and C L Katona, and M T Abou-Saleh, and M M Robertson, and B L Nairac, and D R Edwards, and T Lock, and R A Burns, and D A Harrison, and R W Horton
Changes in human whole blood 5-hydroxytryptamine (5-HT) and platelet 5-HT uptake during treatment with paroxetine, a selective 5-HT uptake inhibitor.
January 1987, Journal of psychopharmacology (Oxford, England),
K M Lawrence, and C L Katona, and M T Abou-Saleh, and M M Robertson, and B L Nairac, and D R Edwards, and T Lock, and R A Burns, and D A Harrison, and R W Horton
Platelet serotonin transporter in depressed children and adolescents: 3H-paroxetine platelet binding before and after sertraline.
July 1998, Journal of the American Academy of Child and Adolescent Psychiatry,
K M Lawrence, and C L Katona, and M T Abou-Saleh, and M M Robertson, and B L Nairac, and D R Edwards, and T Lock, and R A Burns, and D A Harrison, and R W Horton
Platelet high affinity adrenoceptor binding sites labelled with the agonist [3H]UK-14,304, in depressed patients and matched controls.
July 1986, European journal of pharmacology,
Copied contents to your clipboard!